Recently, research on nonfullerene acceptors in organic solar cells has gradually become a hot topic due to such superior characteristics of light absorption and energy-level-convenient manipulation, multiformity of the photoactive material structures, as well as the extensive area in production compared to the fullerene derivatives. However, the nonfullerene acceptors evolved slowly before 2012 and, as a matter of fact, the power conversion efficiency values could only bear 2.0%. Strikingly, nonfullerene acceptors have developed at a fast pace since 2013, with the best device performance of 13.1% now. In this review, recent research progress on nonfullerene acceptors, including small molecules and polymers, are sorted and summarized on the basis of the different characteristics.

Polymer semiconductors have recently attracted considerable attention owing to their (i) excellent optical properties, (ii) processability, (iii) inherent tunability of the energetics, and (iv) synthetic versatility.

C-X-C motif chemokine ligand 8 (CXCL8) is involved in tumor proliferation, migration, and invasion. However, the function of CXCL8 in colorectal cancer (CRC) is controversial. Here, we analyzed RNA-sequencing (RNA-seq) data to identify differentially expressed genes and pathways according to gene ontology (GO) enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways associated with CRC. The levels of the mRNA encoding CXCL8 were significantly increased in early and advanced stages of CRC, as well as in metastases and nonmetastasis cases using RNA-seq analysis (n = 91). These findings were consistent with immunohistochemical analysis of CXCL8 expression (n = 87). Protein-protein interaction (PPI) prediction combined with transcriptional profiling data revealed that CXCL8 levels positively correlated with cAMP responsive element binding protein 1 (CREB1)/ribosomal protein S6 kinase B1 (RPS6KB1) expression, which promotes cell proliferation and differentiation in high expression, while inversely correlated with the expression of Bcl2 associated agonist of cell death (BAD) protein to inhibit apoptosis during the progression of CRC. These findings provide compelling clinical and molecular evidence to support the conclusion that CXCL8 contributes to the genesis and progression of CRC.